• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Gpr1 是一种活跃的趋化素受体,可影响肥胖小鼠的葡萄糖稳态。

Gpr1 is an active chemerin receptor influencing glucose homeostasis in obese mice.

机构信息

Department of PharmacologyFaculty of Medicine, Dalhousie University, 5850 College Street, PO Box 15000, Halifax, Nova Scotia, Canada B3H 4R2.

Department of PharmacologyFaculty of Medicine, Dalhousie University, 5850 College Street, PO Box 15000, Halifax, Nova Scotia, Canada B3H 4R2

出版信息

J Endocrinol. 2014 Aug;222(2):201-15. doi: 10.1530/JOE-14-0069. Epub 2014 Jun 3.

DOI:10.1530/JOE-14-0069
PMID:24895415
Abstract

Chemerin is an adipose-derived signaling protein (adipokine) that regulates adipocyte differentiation and function, immune function, metabolism, and glucose homeostasis through activation of chemokine-like receptor 1 (CMKLR1). A second chemerin receptor, G protein-coupled receptor 1 (GPR1) in mammals, binds chemerin with an affinity similar to CMKLR1; however, the function of GPR1 in mammals is essentially unknown. Herein, we report that expression of murine Gpr1 mRNA is high in brown adipose tissue and white adipose tissue (WAT) and skeletal muscle. In contrast to chemerin (Rarres2) and Cmklr1, Gpr1 expression predominates in the non-adipocyte stromal vascular fraction of WAT. Heterozygous and homozygous Gpr1-knockout mice fed on a high-fat diet developed more severe glucose intolerance than WT mice despite having no difference in body weight, adiposity, or energy expenditure. Moreover, mice lacking Gpr1 exhibited reduced glucose-stimulated insulin levels and elevated glucose levels in a pyruvate tolerance test. This study is the first, to our knowledge, to report the effects of Gpr1 deficiency on adiposity, energy balance, and glucose homeostasis in vivo. Moreover, these novel results demonstrate that GPR1 is an active chemerin receptor that contributes to the regulation of glucose homeostasis during obesity.

摘要

趋化素是一种脂肪组织来源的信号蛋白(脂肪因子),通过激活趋化因子样受体 1(CMKLR1),调节脂肪细胞分化和功能、免疫功能、代谢和葡萄糖稳态。在哺乳动物中,趋化素的第二个受体,G 蛋白偶联受体 1(GPR1),与 CMKLR1 具有相似的亲和力结合趋化素;然而,GPR1 在哺乳动物中的功能基本上是未知的。在此,我们报告鼠 Gpr1 mRNA 的表达在棕色脂肪组织和白色脂肪组织(WAT)和骨骼肌中很高。与趋化素(Rarres2)和 Cmklr1 相反,Gpr1 的表达在 WAT 的非脂肪细胞基质血管部分占优势。尽管体重、肥胖或能量消耗没有差异,杂合子和纯合子 Gpr1 敲除小鼠在高脂肪饮食下比 WT 小鼠更容易出现严重的葡萄糖不耐受。此外,缺乏 Gpr1 的小鼠在丙酮酸耐量试验中表现出较低的葡萄糖刺激胰岛素水平和升高的葡萄糖水平。本研究首次报道了 Gpr1 缺乏对体内肥胖、能量平衡和葡萄糖稳态的影响。此外,这些新的结果表明 GPR1 是一种活跃的趋化素受体,有助于肥胖期间葡萄糖稳态的调节。

相似文献

1
Gpr1 is an active chemerin receptor influencing glucose homeostasis in obese mice.Gpr1 是一种活跃的趋化素受体,可影响肥胖小鼠的葡萄糖稳态。
J Endocrinol. 2014 Aug;222(2):201-15. doi: 10.1530/JOE-14-0069. Epub 2014 Jun 3.
2
ChemR23 knockout mice display mild obesity but no deficit in adipocyte differentiation.ChemR23 敲除小鼠表现出轻度肥胖,但脂肪细胞分化无缺陷。
J Endocrinol. 2013 Nov 7;219(3):279-89. doi: 10.1530/JOE-13-0106. Print 2013 Dec.
3
Ex vivo analysis of serum chemerin activity in murine models of obesity.肥胖症小鼠模型中血清 chemerin 活性的体外分析。
Cytokine. 2018 Apr;104:42-45. doi: 10.1016/j.cyto.2018.02.004. Epub 2018 Feb 6.
4
Chemerin exacerbates glucose intolerance in mouse models of obesity and diabetes.趋化素加剧肥胖和糖尿病小鼠模型的葡萄糖不耐受。
Endocrinology. 2010 May;151(5):1998-2007. doi: 10.1210/en.2009-1098. Epub 2010 Mar 12.
5
CMKLR1 and GPR1 mediate chemerin signaling through the RhoA/ROCK pathway.CMKLR1和GPR1通过RhoA/ROCK信号通路介导凯莫瑞信号传导。
Mol Cell Endocrinol. 2015 Dec 5;417:36-51. doi: 10.1016/j.mce.2015.09.002. Epub 2015 Sep 9.
6
Signaling Properties of Chemerin Receptors CMKLR1, GPR1 and CCRL2.凯莫瑞蛋白受体CMKLR1、GPR1和CCRL2的信号传导特性
PLoS One. 2016 Oct 7;11(10):e0164179. doi: 10.1371/journal.pone.0164179. eCollection 2016.
7
Disruption of the chemokine-like receptor-1 (CMKLR1) gene is associated with reduced adiposity and glucose intolerance.趋化因子样受体-1(CMKLR1)基因的破坏与脂肪减少和葡萄糖不耐受有关。
Endocrinology. 2012 Feb;153(2):672-82. doi: 10.1210/en.2011-1490. Epub 2011 Dec 20.
8
Role of chemerin/CMKLR1 signaling in adipogenesis and osteoblastogenesis of bone marrow stem cells.Chemerin/CMKLR1 信号在骨髓干细胞成脂和成骨分化中的作用。
J Bone Miner Res. 2010 Feb;25(2):222-34. doi: 10.1359/jbmr.091106.
9
Chemerin is a novel adipokine associated with obesity and metabolic syndrome.chemerin是一种与肥胖和代谢综合征相关的新型脂肪因子。
Endocrinology. 2007 Oct;148(10):4687-94. doi: 10.1210/en.2007-0175. Epub 2007 Jul 19.
10
Chemerin--a new adipokine that modulates adipogenesis via its own receptor.chemerin——一种通过自身受体调节脂肪生成的新型脂肪因子。
Biochem Biophys Res Commun. 2007 Nov 3;362(4):1013-8. doi: 10.1016/j.bbrc.2007.08.104. Epub 2007 Aug 27.

引用本文的文献

1
Dynamic allelic expression in mouse mammary glands across the adult developmental cycle.成年发育周期中小鼠乳腺的动态等位基因表达。
Nucleic Acids Res. 2025 Sep 5;53(17). doi: 10.1093/nar/gkaf804.
2
Vascular effects of perivascular adipose tissue-derived chemerin in obesity-associated cardiovascular disease.血管周围脂肪组织来源的凯莫瑞在肥胖相关心血管疾病中的血管效应
Cardiovasc Diabetol. 2025 Jun 13;24(1):249. doi: 10.1186/s12933-025-02814-5.
3
Structure of G protein-coupled receptor GPR1 bound to full-length chemerin adipokine reveals a chemokine-like reverse binding mode.
G 蛋白偶联受体 GPR1 与全长趋化素脂肪因子结合的结构揭示了一种类似趋化因子的反向结合模式。
PLoS Biol. 2024 Oct 28;22(10):e3002838. doi: 10.1371/journal.pbio.3002838. eCollection 2024 Oct.
4
Chemerin in Participants with or without Insulin Resistance and Diabetes.有或无胰岛素抵抗及糖尿病参与者体内的凯莫瑞蛋白
Biomedicines. 2024 Apr 22;12(4):924. doi: 10.3390/biomedicines12040924.
5
The Dual Role of Chemerin in Lung Diseases.趋化素在肺部疾病中的双重作用。
Cells. 2024 Jan 16;13(2):171. doi: 10.3390/cells13020171.
6
Progress in the contrary effects of glucagon-like peptide-1 and chemerin on obesity development.胰高血糖素样肽-1 和趋化素在肥胖发展中相反作用的研究进展。
Exp Biol Med (Maywood). 2023 Nov;248(22):2020-2029. doi: 10.1177/15353702231214270. Epub 2023 Dec 6.
7
An update on the secretory functions of brown, white, and beige adipose tissue: Towards therapeutic applications.棕色、白色和米色脂肪组织分泌功能的最新研究进展:迈向治疗应用。
Rev Endocr Metab Disord. 2024 Apr;25(2):279-308. doi: 10.1007/s11154-023-09850-0. Epub 2023 Dec 5.
8
Mother's warmth from maternal genes: genomic imprinting of brown adipose tissue.来自母体基因的母亲温暖:棕色脂肪组织的基因组印记
Evol Med Public Health. 2023 Sep 29;11(1):379-385. doi: 10.1093/emph/eoad031. eCollection 2023.
9
The Role of Chemerin in Metabolic and Cardiovascular Disease: A Literature Review of Its Physiology and Pathology from a Nutritional Perspective.从营养角度看 chemerin 在代谢和心血管疾病中的作用:对其生理学和病理学的文献综述。
Nutrients. 2023 Jun 25;15(13):2878. doi: 10.3390/nu15132878.
10
α-NETA down-regulates CMKLR1 mRNA expression in ileum and prevents body weight gains collaborating with ERK inhibitor PD98059 in turn to alleviate hepatic steatosis in HFD-induced obese mice but no impact on ileal mucosal integrity and steatohepatitis progression.α-NETA 下调回肠 CMKLR1 mRNA 表达,并与 ERK 抑制剂 PD98059 协同作用,防止体重增加,从而减轻 HFD 诱导肥胖小鼠的肝脂肪变性,但对回肠黏膜完整性和脂肪性肝炎进展没有影响。
BMC Endocr Disord. 2023 Jan 10;23(1):9. doi: 10.1186/s12902-023-01267-9.